Stock CGN COGNETIVITY NEUROSCIENCES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Cognetivity Neurosciences Ltd.

Equities

CGN

CA19243C1005

Delayed Canadian Securities Exchange
Other stock markets
 15:21:15 01/05/2024 BST 		5-day change 1st Jan Change
0.015 CAD -25.00% Intraday chart for Cognetivity Neurosciences Ltd. -25.00% 0.00%
2023 Cognetivity Neurosciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023 CI
2023 Cognetivity Neurosciences Ltd. announced that it has received CAD 0.01 million in funding CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023
Cognetivity Neurosciences Ltd. and Uc Health Partner to Improve Early Detection of Cognitive Impairment in Usa
Cognetivity Neurosciences Ltd. Announces Collaboration with the Mediclinic Group
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023
Cognetivity Neurosciences Ltd. Announces Eisai's Leqembi Approval for the Treatment of Alzheimer's Disease
Cognetivity Neurosciences Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2023
Clairvo Technologies, Inc. Announces Strategic Partnership with Cognetivity Neurosciences, Inc
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Full Year Ended January 31, 2023
Cognetivity Neurosciences Ltd. Auditor Raises 'Going Concern' Doubt
Cognetivity Neurosciences Ltd. Announces Collaboration with the Alzheimer's Society to Further Expand Its AI Algorithms
Cognetivity Neurosciences Ltd. Announces Agreement with Mitsui Sumitomo Aioi Life Insurance of Japan to Provide CognICA Technology to Customers
Cognetivity Neurosciences Ltd. Appoints Karimah Es Sabar to Its Board Director
Cognetivity Neurosciences Enters Commercial Agreement with Conka
Cognetivity Neurosciences Announces Commercial Deployment at Leading Psychiatry and Neurology Centre in UAE
Cognetivity Announces Further Scientific Evidence of its AI-Powered CognICA(TM) Platform's Ability to Detect and Monitor Cognitive Impairment in Patients With Multiple Sclerosis
Cognetivity Neurosciences Ltd. Announces Release an Update Version of Its Tool, CognICATM
Cognetivity Neurosciences Ltd.'s CognICA Platform Successfully Monitors Cognitive Performance in Alzheimer's Patients Receiving Disease- Modifying Therapy
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022
Cognetivity Neurosciences Ltd. Appoints Dr. Lance Black, MD, MBID as New Advisory Board Member
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CGN Stock
  4. News Cognetivity Neurosciences Ltd.
  5. Other languages